Jakob Krause Haaber

Company: CRISPR Therapeutics

Job title: Vice President, CRISPR & Delivery Technologies

Seminars:

Unveiling the Process of Transforming Antimicrobial Therapy Through CRISPR-assisted Engineering of Phages 1:00 pm

Creating supercharged synthetic phages as highly effective weapons in the fight against multidrug-resistant bacterial infections Benefits of engineering natural phages to broaden their host range, minimize resistance and improve efficacy Updates from the world’s first clinical trial of orally dosing SNIPR001; a cocktail of CRISPR-armed phages How to identify optimal phage candidates for downstream engineering?Read more

day: Pre-Conference Day Track B PM